Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. (Q53341193)

13 May 2018

title

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. (English)

1 reference

13 May 2018

malignant pleural mesothelioma

main subject

patient

0 references

1 reference

1

1 reference

13 May 2018

author name string

Venkatraman ES

series ordinal

2

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

13 May 2018

The Annals of Thoracic Surgery

published in

1 reference

13 May 2018

volume

68

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

1799-1804

1 reference

13 May 2018

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

The importance of surgical staging in the treatment of malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

A new international staging system for lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Lymph node mapping of esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Surgically debulked malignant pleural mesothelioma: results and prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Laparoscopy: An important tool in the staging of malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901038-3

10.1016/S0003-4975(99)01038-3

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

10585061

1 reference

13 May 2018